Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

非格司亭生物类似药（中国医学科学院医学生物学研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

Drug Alias NamerhG-CSF (Institute of Medical Biology Chinese Academy of Medical Sciences)非格司亭生物仿制药（中国医学科学院医学生物学研究所）重组人粒细胞刺激因子（中国医学科学院医学生物学研究所）rhGM-CSF (Institute of Medical Biology Chinese Academy of Medical Sciences)Recombinant human granulocyte-macrophage colony-stimulating factor (Institute of Medical Biology Chinese Academy of Medical Sciences) +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsLeukopeniaMyelodysplastic Syndromes

Global Approved IndicationsLeukopeniaMyelodysplastic Syndromes

Approved Indications in ChinaLeukopeniaMyelodysplastic Syndromes

Original Approved Country/TerritoryMainland China

Original Approved Date2001/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesInstitute Of Medical Biology, Chinese Academy Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biology, Chinese Academy Of Medical Sciences

Inactive CompaniesN/A

Active IndicationsLeukopeniaMyelodysplastic Syndromes

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02